St  ||| S:0 E:3 ||| NNP
Jude  ||| S:3 E:8 ||| NNP
Medical  ||| S:8 E:16 ||| NNP
Portico  ||| S:16 E:24 ||| NNP
valve  ||| S:24 E:30 ||| FW
Transcatheter  ||| S:30 E:44 ||| FW
aortic  ||| S:44 E:51 ||| FW
valve  ||| S:51 E:57 ||| FW
implantation  ||| S:57 E:70 ||| FW
is  ||| S:70 E:73 ||| VBZ
increasingly  ||| S:73 E:86 ||| RB
being  ||| S:86 E:92 ||| VBG
used  ||| S:92 E:97 ||| VBN
to  ||| S:97 E:100 ||| TO
treat  ||| S:100 E:106 ||| VB
high-risk  ||| S:106 E:116 ||| JJ
patients  ||| S:116 E:125 ||| NNS
with  ||| S:125 E:130 ||| IN
symptomatic  ||| S:130 E:142 ||| JJ
aortic  ||| S:142 E:149 ||| JJ
valve  ||| S:149 E:155 ||| JJ
disease ||| S:155 E:162 ||| NN
.  ||| S:162 E:164 ||| .
However ||| S:164 E:171 ||| RB
,  ||| S:171 E:173 ||| ,
challenges  ||| S:173 E:184 ||| VBZ
still  ||| S:184 E:190 ||| RB
remain  ||| S:190 E:197 ||| VB
with  ||| S:197 E:202 ||| IN
current  ||| S:202 E:210 ||| JJ
devices ||| S:210 E:217 ||| NNS
,  ||| S:217 E:219 ||| ,
both  ||| S:219 E:224 ||| DT
in  ||| S:224 E:227 ||| IN
terms  ||| S:227 E:233 ||| NNS
of  ||| S:233 E:236 ||| IN
the  ||| S:236 E:240 ||| DT
procedure  ||| S:240 E:250 ||| NN
and  ||| S:250 E:254 ||| CC
the  ||| S:254 E:258 ||| DT
outcome ||| S:258 E:265 ||| NN
.  ||| S:265 E:267 ||| .
The  ||| S:267 E:271 ||| DT
St  ||| S:271 E:274 ||| NNP
Jude  ||| S:274 E:279 ||| NNP
Medical  ||| S:279 E:287 ||| NNP
Portico  ||| S:287 E:295 ||| NNP
transcatheter  ||| S:295 E:309 ||| VBD
valve  ||| S:309 E:315 ||| JJ
system  ||| S:315 E:322 ||| NN
is  ||| S:322 E:325 ||| VBZ
designed  ||| S:325 E:334 ||| VBN
to  ||| S:334 E:337 ||| TO
mitigate  ||| S:337 E:346 ||| VB
some  ||| S:346 E:351 ||| DT
of  ||| S:351 E:354 ||| IN
these  ||| S:354 E:360 ||| DT
difficulties ||| S:360 E:372 ||| NNS
.  ||| S:372 E:374 ||| .
We  ||| S:374 E:377 ||| PRP
describe  ||| S:377 E:386 ||| VBP
the  ||| S:386 E:390 ||| DT
device  ||| S:390 E:397 ||| NN
characteristics  ||| S:397 E:413 ||| NNS
and  ||| S:413 E:417 ||| CC
how  ||| S:417 E:421 ||| WRB
the  ||| S:421 E:425 ||| DT
device  ||| S:425 E:432 ||| NN
may  ||| S:432 E:436 ||| MD
impact  ||| S:436 E:443 ||| VB
on  ||| S:443 E:446 ||| IN
a  ||| S:446 E:448 ||| DT
TAVI  ||| S:448 E:453 ||| NNP
procedure ||| S:453 E:462 ||| NN
.  ||| S:462 E:464 ||| .
An  ||| S:464 E:467 ||| DT
overview  ||| S:467 E:476 ||| NN
of  ||| S:476 E:479 ||| IN
the  ||| S:479 E:483 ||| DT
clinical  ||| S:483 E:492 ||| JJ
experiences  ||| S:492 E:504 ||| NNS
with  ||| S:504 E:509 ||| IN
the  ||| S:509 E:513 ||| DT
Portico  ||| S:513 E:521 ||| JJ
valve  ||| S:521 E:527 ||| JJ
system  ||| S:527 E:534 ||| NN
is  ||| S:534 E:537 ||| VBZ
also  ||| S:537 E:542 ||| RB
described ||| S:542 E:551 ||| VBN
.  ||| S:551 E:553 ||| .
